Evidence map›Paper›PMID 40082971›Full record

ArticleAntimicrobial resistance and infection control2025

High incidence of multidrug-resistant organisms and modifiable risk factors associated with surgical site infections: a cohort study in a tertiary medical center in Kuala Lumpur, Malaysia from 2020 to 2023.

Anis Najwa Muhamad, Cindy Shuan Ju Teh, Mohd Rusdi Draman, Yohan Khirusman Adnan, Azlina Amir Abbas, Tak Loon Khong, Vairavan Narayanan, Soo Nee Tang, Rina Karunakaran, Norhafizah Ab Manan and 9 more

Abstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. GenusMicroorganisms · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Anis Najwa MuhamadDepartment of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Cindy Shuan Ju TehDepartment of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50603, Malaysia. cindysjteh@um.edu.my.
Mohd Rusdi DramanDepartment of Orthopaedic Surgery, Faculty of Medicine, National Orthopaedic Centre of Excellence for Research and Learning (NOCERAL), Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Yohan Khirusman AdnanDepartment of Orthopaedic Surgery, Faculty of Medicine, National Orthopaedic Centre of Excellence for Research and Learning (NOCERAL), Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Azlina Amir AbbasDepartment of Orthopaedic Surgery, Faculty of Medicine, National Orthopaedic Centre of Excellence for Research and Learning (NOCERAL), Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Tak Loon KhongDepartment of Surgery, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Vairavan NarayananDepartment of Surgery, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Soo Nee TangDepartment of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Rina KarunakaranDepartment of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Norhafizah Ab MananVsynova Partners, Inc, 8400 Corporate Drive, Ste 130, Landover, MD, 20785, USA.
Anjanna KukrejaDepartment of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Siti Zuhairah Mohamad RazaliDepartment of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Chun Yoong ChamDepartment of Surgery, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Robert D HontzDepartment of Emerging Infections, United States Naval Medical Research Unit INDO PACIFIC, Singapore and Phnom Penh, Cambodia.
Michael J GregoryDepartment of Emerging Infections, United States Naval Medical Research Unit INDO PACIFIC, Singapore and Phnom Penh, Cambodia.
Anca SelariuDepartment of Emerging Infections, United States Naval Medical Research Unit INDO PACIFIC, Singapore and Phnom Penh, Cambodia.
Huy C NguyenDepartment of Emerging Infections, United States Naval Medical Research Unit INDO PACIFIC, Singapore and Phnom Penh, Cambodia.
Andrew G LetiziaDepartment of Emerging Infections, United States Naval Medical Research Unit INDO PACIFIC, Singapore and Phnom Penh, Cambodia.
Sasheela Sri La Sri PonnampalavanarDepartment of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50603, Malaysia. sheela@ummc.edu.my.

Funding

Armed Forces Health Surveillance Division, Global Emerging Infectious Diseases Branch IF066-2020
6 · The paper itself

Abstract

backgroundSurgical site infections (SSIs) are a persistent challenge in healthcare, contributing significantly to patient morbidity, mortality, and healthcare costs. Despite advancements in preventive measures, SSIs remain prevalent, especially in countries like Malaysia where rates are higher than in high-income nations.

methodsA prospective, cohort study was conducted at the University Malaya Medical Center (UMMC), Malaysia, from November 2020 to May 2023. Clinical and microbiological data were collected, and logistic regression were performed to identify risk factors associated with SSIs.

resultsA total of 1,815 patients undergoing orthopedic, neurosurgical, and general surgical procedures were monitored for SSIs. The incidence rate of SSIs was 3.23 per 100 procedures (n = 71) with significant associations observed between SSI occurrence and prolonged surgical duration > 100 min, extended hospitalization > 5 days, trauma-to-surgery interval > 8 days, and presence of implants. Common pathogens isolated included Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Multidrug-resistant organisms (MDROs) were identified in 42.1% of the total isolates.

conclusionsIn this study, a high rate of MDRO and risk factors for SSI were identified. It emphasises the need for ongoing surveillance to guide infection prevention strategies and antimicrobial stewardship programs. Future research should prioritize evaluating the impact of targeted interventions tailored to identified risk factors to optimize surgical patient outcomes.

Indexed as

Drug Resistance, Multiple, BacterialSurgical Wound InfectionAdultAgedAnti-Bacterial AgentsFemaleHumansIncidenceMalaysiaMaleMiddle AgedProspective StudiesRisk FactorsTertiary Care CentersYoung AdultAnti-Bacterial AgentsAntimicrobial resistanceMultidrug-resistant organismsSurgical site infection

Identifiers

PMID40082971
PMCPMC11907968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.